Febuxostat structure
Febuxostat
Crystalline SolidFebuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with
gout. Hyperuricemia is defined as a serum uric acid concentration
exceeding the limit of solubility. It predisposes affected persons to
gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other
tissues. Crystal deposition is asymptomatic, but it is revealed by bouts
of
Find 70 Related Holders
Shandong Xinhua Pharmaceutical Company Limited
China
China
API Registration Country
API Active
-
Founded in:
1998-11-20 -
Country:
China -
Address:
Chemical Industry Zone, Zibo High-tech Industrial Development Zone -
Tax NO.:
91370300164103727C -
Registered Funds:
682,407,635 yuan -
Website:
-
Email:
LINHAI TIANYU PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
JIANGXI SYNERGY PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
AMI LIFESCIENCES PRIVATE LTD
United States
United States
API Registration Country
API Active
WANBANG BIOPHARMACEUTICALS
United States
United States
API Registration Country
API Active
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
CHONGQING SHENGHUAXI PHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
HANMI FINE CHEMICAL CO.,LTD.
Japan
Japan
API Registration Country
API Active
Shandong Boyuan Pharmaceutical Co.,Ltd.
Japan
Japan
API Registration Country
API Active
Zhejiang Ausun Pharmaceutical Co.,Ltd.
Japan
Japan
API Registration Country
API Active
Recommended Suppliers of Febuxostat
-
Amitychem
CN1 YR
Contact Supplier -
Hainan Flying International Trade Co., L
CN1 YR
Contact Supplier -
Wuhan Dongkangyuan Technology Co., Ltd.
CN1 YR
Contact Supplier -
Shaanxi TNJONE Pharmaceutical Co., Ltd
CN1 YR
Contact Supplier -
Xian ZB Biotech Co.,Ltd
CN1 YR
Contact Supplier